Archive for 2006/11


Complementary Medicine Has A Role In The Treatment Of Allergic Diseases

Complementary or alternative medicine (CAM) has increased tremendously in popularity in the United States. At a symposium held at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI), a team of experts discussed the safety and efficacy of CAM for the management of allergic diseases. [click link for full article]
(more...)


11/13/2006 | Complememntary & Alternative Medicine | Trackback | Comments Off

The Global Initiative For Asthma (GINA) Announces Major Changes In Its Guidance For Asthma Management And Prevention

The Global Initiative for Asthma (GINA) today announced the release of a new Global Strategy for Asthma Management and Prevention. In a major revision of GINA's 2002 Global Strategy, the new guidelines put the emphasis on asthma control. [click link for full article]
(more...)


11/13/2006 | Respiratory & Asthma | Trackback | Comments Off

American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy

The American Thoracic Society (ATS) has published a new statement on the pathogenesis, prevention and treatment of liver damage caused by anti-tuberculosis (TB) medications. [click link for full article]
(more...)


11/13/2006 | Respiratory & Asthma | Trackback | Comments Off

Fibrosis Patients Who used Pulmozyme Experienced A Slower Rate Of Lung Function Decline And An Immediate Improvement In Lung Function

Data presented this past Friday at the North America Cystic Fibrosis Conference (NACFC) in Denver showed that cystic fibrosis patients who used Pulmozyme experienced a slower rate of lung function decline and an immediate improvement in lung function, as compared to cystic fibrosis patients not treated with Pulmozyme. [click link for full article]
(more...)


11/12/2006 | Respiratory & Asthma | Trackback | Comments Off

Which Type Of Whooping Cough Vaccine Should Be Used?

Vickers and colleagues analyzed the incidence of pertussis reported to the Saskatoon Regional Health Authority in Saskatchewan between Jan.1, 1995, and Sept. 30, 2005.They found that children aged less than 1 year or aged between 1 and 4 years who had only received whole-cell pertussis (wP), or a combination of wP and acellular pertussis (aP), had a lower incidence of pertussis than children who had received only aP, whereas a reverse trend was seen in children aged 5-9 years. [click link for full article]
(more...)


11/09/2006 | Respiratory & Asthma | Trackback | Comments Off

Alcohol Bad For Lungs As Well As Liver

Chronic alcohol abuse disrupts the proteins that keep fluids out of the lung, lowers a protective antioxidant, disrupts immune defenses and can lead to a condition known as 'alcoholic lung,' according to research to be presented at the conference, "Physiological Genomics and Proteomics of Lung Disease." The findings give insight into how excessive drinking can harm the molecular life of the lung and lead to serious illness, including pneumonia and acute respiratory distress syndrome (ARDS). [click link for full article]
(more...)


11/08/2006 | Respiratory & Asthma | Trackback | Comments Off

Why The Flu Makes Some People Sicker Than Others - Identifying Key Genes Could Help Identify Those Most At Risk

With lessons from the 1918 flu pandemic in the rearview mirror and the avian flu a looming obstacle in the road ahead, researchers from Southern Illinois University School of Medicine are trying to understand why a flu virus kills some people but not others.  With the help of some high tech equipment, well-defined mouse models and lots of analytical know how, physiologists are beginning to hone in on the secret to this differential response. [click link for full article]
(more...)


11/07/2006 | Respiratory & Asthma | Trackback | Comments Off

Numax(R) Achieves Primary Endpoint In Preliminary Analysis Of Data From Comparative Phase 3 Trial With Synagis(R)

MedImmune, Inc. (Nasdaq: MEDI) today announced preliminary results from a Phase 3 pivotal study showing that Numax met its primary endpoint of non-inferiority by reducing the incidence of hospitalizations caused by respiratory syncytial virus (RSV) in infants at high risk for serious RSV disease by 26 percent when compared to Synagis(R) (palivizumab). [click link for full article]
(more...)


11/07/2006 | Respiratory & Asthma | Trackback | Comments Off

Lung DCs Legitimate Targets For Treating Asthma

Allergic asthma is caused by an unwanted immune response known as a Th2 cell response. Most treatments for asthma currently target this Th2 cell response and its downstream effects. However, immune cells known as dendritic cells (DCs) are crucial activators of all T cell responses, including the Th2 cell response in asthma, so therapies that target DC function in the airways might represent a new way to treat individuals with allergic asthma. [click link for full article]
(more...)


11/06/2006 | Respiratory & Asthma | Trackback | Comments Off

Health Canada Advises Consumers Not To Use Four Unauthorized Natural Health Products That Claim To Treat Serious Diseases

Health Canada is advising consumers not to use four unauthorized natural health products that are promoted to treat serious health conditions such as cancer, arthritis and heart disease because such unapproved health claims are in violation of the Food and Drugs Act. These unproven health claims may mislead patients to use the unauthorized products in place of proven, approved treatment. [click link for full article]
(more...)


11/06/2006 | Complememntary & Alternative Medicine | Trackback | Comments Off

« Previous Entries
Next Entries »

© 2006 MBGJ.Org Limited Trading as Natural-Remedies-Clinic

All rights reserved - Designated trademarks and brands are the property of their respective owners

Natural Remedies Clinic - Main Site


Page Sponsors

Hair Loss Treatment -Silicone Immune Toxicity Syndrome -

>-- Top of Page --<